Total planned funding: $5,457,335,310
Clear active filters
Private Contractor
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $907,906,949 |
| Tanzania | $741,259,005 |
| Zambia | $682,867,095 |
| Mozambique | $475,936,606 |
| Uganda | $452,890,241 |
| Kenya | $347,173,571 |
| Ethiopia | $262,895,571 |
| Côte d'Ivoire | $242,428,479 |
| South Africa | $232,059,627 |
| Zimbabwe | $205,380,422 |
| Rwanda | $172,895,394 |
| Haiti | $153,311,797 |
| Vietnam | $81,275,481 |
| Namibia | $63,713,028 |
| Democratic Republic of the Congo | $63,231,221 |
| Eswatini | $60,821,094 |
| Botswana | $50,544,529 |
| Malawi | $36,066,572 |
| Cameroon | $30,705,537 |
| Ukraine | $23,844,199 |
| Burundi | $21,261,965 |
| Indonesia | $17,720,336 |
| Central America Region | $16,437,330 |
| Lesotho | $15,387,745 |
| Guyana | $12,462,114 |
| South Sudan | $11,786,997 |
| Ghana | $11,457,840 |
| West Africa Region | $10,048,457 |
| Caribbean Region | $9,228,526 |
| Dominican Republic | $7,967,236 |
| Western Hemisphere Region | $7,661,884 |
| Cambodia | $5,702,050 |
| Angola | $5,246,445 |
| Asia Regional Program | $5,135,000 |
| Central Asia Region | $4,282,129 |
| India | $4,098,272 |
| Russia | $2,620,000 |
| China | $716,150 |
| Burma | $550,000 |
| enumerations.Philippines | $358,416 |
| Thailand | $0 |
Organizational Types
| Private Contractor | $5,457,335,310 |
Program Areas
| Treatment | $3,031,586,472 |
| Governance and Systems | $806,436,825 |
| Care | $728,266,259 |
| Prevention | $646,489,779 |
| Testing | $237,595,772 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $2,124,518,301 |
| HTXS: Treatment: Adult Treatment | $808,626,517 |
| OHSS: Health Systems Strengthening | $420,935,592 |
| HBHC: Care: Adult Care and Support | $329,219,163 |
| HLAB: Laboratory Infrastructure | $247,590,108 |
| HVCT: Testing: HIV Testing and Counseling | $237,595,772 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $228,131,738 |
| HKID: Care: Orphans and Vulnerable Children | $217,514,122 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $172,142,637 |
| HVSI: Strategic Information | $137,911,125 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $129,307,110 |
| HVTB: Care: TB/HIV | $122,044,047 |
| PDTX: Treatment: Pediatric Treatment | $98,441,654 |
| PDCS: Care: Pediatric Care and Support | $59,488,927 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $57,873,655 |
| HMIN: Biomedical Prevention: Injection Safety | $30,229,416 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $17,083,098 |
| HMBL: Biomedical Prevention: Blood Safety | $11,722,125 |
Top Partner Programs
Partnership for Supply Chain Management:
$2,255,723,085
View countries
Chemonics International:
$1,555,569,737
View countries
Abt Associates:
$227,576,640
View countries
University Research Corporation, LLC:
$209,431,349
View countries